Mathias Locher
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Oncology 13
- CAR-T cell therapy research 6
- HER2/EGFR in Cancer Research 3
-
- Biochemical Acid Research Studies 4
- Co-authors
- Patrick Alexander Baeuerle (7 shared papers)Bernd Schlereth (5 shared papers)Peter Kufer (4 shared papers)Klaus Brischwein (4 shared papers)Robert B. Hermann (5 shared papers)Andreas Wolf (2 shared papers)Nadja S. Prang (3 shared papers)Norbert G. Knebel (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Metabolism (2 papers)Journal of Molecular Medicine (2 papers)Molecular Immunology (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Mathias Locher
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Radiology, Nuclear Medicine and Imaging 428
- Oncology 451
- Immunology 333
- Biochemistry 88
- Pharmacology 52
Countries citing papers authored by Mathias Locher
This map shows the geographic impact of Mathias Locher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Locher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Locher more than expected).
Fields of papers citing papers by Mathias Locher
This network shows the impact of papers produced by Mathias Locher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Locher. The network helps show where Mathias Locher may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathias Locher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 222 | |
| 2 | 2007 | 160 | |
| 3 | 2005 | 113 | |
| 4 | 2015 | 81 | |
| 5 | 2008 | 65 | |
| 6 | 2006 | 54 | |
| 7 | 2006 | 50 | |
| 8 | 2003 | 49 | |
| 9 | 2005 | 46 | |
| 10 | 2006 | 45 | |
| 11 | 1997 | 32 | |
| 12 | 2000 | 32 | |
| 13 | 2004 | 31 | |
| 14 | 1995 | 29 | |
| 15 | 2000 | 27 | |
| 16 | 2014 | 22 | |
| 17 | 2003 | 21 | |
| 18 | 1985 | 19 | |
| 19 | 1999 | 17 | |
| 20 | 2000 | 17 |
About Mathias Locher
Mathias Locher is a scholar working on Oncology, Biochemistry, Radiology, Nuclear Medicine and Imaging, Pharmacology and Spectroscopy, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (6 papers), Analytical Chemistry and Chromatography (5 papers), Glycosylation and Glycoproteins Research (4 papers), Biochemical Acid Research Studies (4 papers), Alcoholism and Thiamine Deficiency (3 papers), HER2/EGFR in Cancer Research (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (428 citations), Oncology (451 citations), Immunology (333 citations), Biochemistry (88 citations) and Pharmacology (52 citations). Mathias Locher has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Patrick Alexander Baeuerle, Bernd Schlereth, Peter Kufer, Klaus Brischwein, Robert B. Hermann, Andreas Wolf, Nadja S. Prang, Norbert G. Knebel, Robert Hofmeister and Peter A. Kiener. Their work appears in journals such as The Journal of Clinical Pharmacology, Metabolism, Journal of Molecular Medicine, Molecular Immunology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.